Logo image of CNCE

CONCERT PHARMACEUTICALS INC (CNCE) Stock Analyst Earnings Estimates

NASDAQ:CNCE - Nasdaq - US2060221056 - Common Stock - Currency: USD

8.37  +0.01 (+0.12%)

After market: 8.4 +0.03 (+0.36%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CNCE revenue by date.CNCE revenue by date.
1.1M
-89.52%
7.9M
618.18%
32.578M
312.38%
101.745K
-99.69%
13.117M
12,792.03%
32.379M
146.85%
98.278M
203.52%
195.14M
98.56%
280.94M
43.97%
393.58M
40.09%
441.06M
12.06%
483.99M
9.73%
EBITDA
YoY % growth
CNCE ebitda by date.CNCE ebitda by date.
-77.3M
-42.10%
-71M
8.15%
-76.029M
-7.08%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CNCE ebit by date.CNCE ebit by date.
-79M
-42.09%
-72.6M
8.10%
-77.508M
-6.76%
-123.736M
-59.64%
-137.334M
-10.99%
-129.491M
5.71%
-79.059M
38.95%
3.768M
104.77%
78.9M
1,993.95%
177.26M
124.66%
217.15M
22.50%
253.18M
16.59%
Operating Margin
CNCE operating margin by date.CNCE operating margin by date.
-7,181.82%-918.99%-237.92%-121,614.29%-1,046.99%-399.92%-80.44%1.93%28.08%45.04%49.23%52.31%
EPS
YoY % growth
CNCE eps by date.CNCE eps by date.
-3.29
-37.66%
-2.40
27.05%
-2.30
4.17%
-2.82
-22.75%
-2.80
0.94%
-2.11
24.51%
-0.84
60.39%
0.03
103.05%
0.71
2,680.00%
1.68
136.69%
1.85
10.33%
2.07
11.85%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 22 Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
-0.65
35.87%
-0.83
19.79%
-0.71
-20.15%
-0.70
-21.34%
-0.66
-2.36%
Revenue
Q2Q % growth
115.597K
789.20%

-100.00%

-100.00%
5.1M
4,311.89%
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-28.307M
14.10%
-38.76M
-7.58%
-44.88M
27.28%
-48.96M
-65.37%
-43.86M
-54.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
-0.58
25.64%
-0.600.023.95%
Q2 2022
Q2Q % growth
-0.59
-468.75%
-0.860.2731.75%
Q1 2022
Q2Q % growth
-1.03
-53.73%
-0.93-0.10-10.48%
Q4 2021
Q2Q % growth
-1.01
-46.38%
-0.74-0.27-35.64%
Q3 2021
Q2Q % growth
-0.78
-30.00%
-0.830.055.59%
Q2 2021
Q2Q % growth
0.16
139.02%
-0.750.91121.31%
Q1 2021
Q2Q % growth
-0.67
4.29%
-0.700.034.53%
Q4 2020
Q2Q % growth
-0.69
19.77%
-0.790.1012.83%
Q3 2020
Q2Q % growth
-0.60
16.67%
-0.750.1519.97%
Q2 2020
Q2Q % growth
-0.41
47.44%
-0.700.2941.74%
Q1 2020
Q2Q % growth
-0.70
24.73%
-0.790.0911.87%
Q4 2019
Q2Q % growth
-0.86 -0.80-0.06-7.31%
Q3 2019
Q2Q % growth
-0.72 -0.850.1315.39%
Q2 2019
Q2Q % growth
-0.78 -0.900.1213.71%
Q1 2019
Q2Q % growth
-0.93 -0.63-0.30-47.46%
CNCE Yearly EPS VS EstimatesCNCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2022
Q2Q % growth
8K
-98.53%
84.15K-76.15K-90.49%
Q2 2022
Q2Q % growth
21K
-99.93%
84.15K-63.15K-75.04%
Q1 2022
Q2Q % growth
84.997K-84.997K-100.00%
Q4 2021
Q2Q % growth
13K 25.5K-12.5K-49.02%
Q3 2021
Q2Q % growth
543K
-63.80%
63.75K479.25K751.76%
Q2 2021
Q2Q % growth
32.017M
400.27%
63.75K31.953M50,122.75%
Q1 2021
Q2Q % growth
382.5K-382.5K-100.00%
Q2 2020
Q2Q % growth
6.4M 1.703K6.398M375,619.15%
Q1 2020
Q2Q % growth

-100.00%
5.824K-5.824K-100.00%
Q4 2019
Q2Q % growth
13.597K-13.597K-100.00%
Q3 2019
Q2Q % growth
59.497K-59.497K-100.00%
Q2 2019
Q2Q % growth
51K-51K-100.00%
Q1 2019
Q2Q % growth
1M 5.454M-4.454M-81.66%
CNCE Yearly Revenue VS EstimatesCNCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.78% 0.78% 0% -0.36%
Revenue33.33% 33.33% 0% -43.88%